70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Skandinavischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
12.05. - 15.05.2019, Würzburg
ePoster Montag, 13.05.2019
Neurochirurgische Onkologie III/Neurosurgical oncology III
Meeting Abstract
(P071)
[Full Text]
The role of the calpain/calpastatin system in chemoresistance of glioblastoma
Hannen R, Chen Cy, Schilling O, Bartsch JW, Nimsky C[Full Text]
Meeting Abstract
(P072)
[Full Text]
Decision for extent of surgical resection in elderly glioblastoma
Ahmadipour Y, Müller O, Dammann P, Pierscianek D, Darkwah Oppong M, Grzywotz A, Sure U, Jabbarli R[Full Text]
Meeting Abstract
(P073)
[Full Text]
The expression of the intercellular communication proteins GAP43 and Cx43 in diffuse and anaplastic gliomas
Krigers A, Moser P, Fritsch H, Thomé C, Freyschlag CF[Full Text]
Meeting Abstract
(P074)
[Full Text]
The synthetic ligand Apelin-F13A binds and activates glioblastoma APLNR reducing the pro-invasive side effect of anti-angiogenic therapy
Kälin R, Stöcklein V, Li M, Reinhard S, Mastrella G, Wagner E, Tonn JC, Glass R[Full Text]
Meeting Abstract
(P075)
[Full Text]
Early clinical experience with gliovac (ERC1671) antitumor vaccination therapy for recurrent glioblastoma
Heiland T, Karpel-Massler G, Wirtz CR, Halatsch ME[Full Text]
Meeting Abstract
(P076)
[Full Text]
Current evidence for the application of blood-based biomarkers in high grade gliomas
Pierscianek D, Ahmadipour Y, Darkwah Oppong M, Rauschenbach L, Michel A, Sure U, Jabbarli R[Full Text]
Meeting Abstract
(P077)
[Full Text]
Microenvironmental release of CHI3L1 drives transcriptional re-programming and promotes proliferation
Wurm J, Behringer S, Franco P, Beck J, Schnell O, Heiland DH[Full Text]
Meeting Abstract
(P078)
[Full Text]
Extracellular released glutamate stimulates a proliferative-autocrine-loop in glioblastoma
Garrelfs N, Behringer S, Wurm J, Beck J, Schnell O, Heiland DH[Full Text]
Meeting Abstract
(P079)
[Full Text]
Effects of protocadherin gamma C3 (PCDHGC3) knockout on proliferation, invasion and self-renewal abilities in glioblastoma cell lines
Kempe CD, Baptista F, Fabregat MC, Li N, Hagemann C, Burek M[Full Text]
Meeting Abstract
(P080)
[Full Text]
Pro-invasive side effects of bevacizumab and ramucirumab therapy in proneural and classical GBM is mediated by apelin signalling and reducible by apelin receptor blockade
Stöcklein V, Li M, Harter PN, Zdouc N, Mittelbronn M, Tonn JC, Glass R, Kälin R[Full Text]
Meeting Abstract
(P081)
[Full Text]
Meningeosis neoplastica in patients with high-grade gliomas
Sachkova A, Komboz F, Petrov A, Bock HC, Mielke D, Rohde V, Malinova V[Full Text]
Meeting Abstract
(P082)
[Full Text]
Interim results from a proof-of-concept clinical trial assessing the safety of the coordinated undermining of survival paths by 9 repurposed drugs (version 3) combined with metronomic temozolomide (CUSP9v3) protocol for recurrent glioblastoma
Halatsch ME, Kast RE, Karpel-Massler G, Schmitz B, Zolk O, Bullinger L, Mayer-Steinacker R, Maier L, Scheuerle A, Mayer B, Schmidt C, Zeiler K, Elshaer Z, Awad F, Panther P, Schmelzle B, Beckers K, Siegelin MD, Westhoff MA, Wirtz CR, Bouche G, Heiland T[Full Text]
